Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05162755
Title S095029 as Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies Followed by an Expansion Part With Triple Combinations in Patients With Metastatic Gastric or Colorectal Cancers
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Institut de Recherches Internationales Servier
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
START Midwest Grand Rapids Michigan 49546 United States Details
Mary Crowley Cancer Research Dallas Texas 75230 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
The START Center for Cancer Care San Antonio Texas 78229 United States Details
Princess Margaret Cancer Centre Toronto Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field